Literature DB >> 7551914

Natural killer cell proliferation is dependent on human serum and markedly increased utilizing an enriched supplemented basal medium.

B A Pierson1, P B McGlave, W S Hu, J S Miller.   

Abstract

We studied the effects of basal medium and human serum on the ex vivo expansion of CD56+/CD3- natural killer cells (NK). We demonstrated that sorted NK cultured for 18 days with 10% human AB serum without accessory cells in a 2:1 DMEM/F12 basal medium expanded significantly greater (6.4 +/- 0.9-fold, n = 14) than when cultured in standard RPMI 1640 basal medium (3.7 +/- 0.67-fold, n = 16; p = 0.019). Supplementation of the DMEM/F12 mixture with 2-mercaptoethanol (2ME), ethanolamine, L-ascorbic acid, and sodium selenite significantly augmented NK proliferation (16.3 +/- 2.5-fold, n = 11; p < 0.001) compared with DMEM/F12 without supplements. NK growth kinetics demonstrated that both the growth rate and the duration of exponential growth were increased by medium supplements. Addition of 2ME-containing supplements to cultures of NK with accessory cells augments NK proliferation, recruits NK progenitors, and has a serum-sparing effect. For the large-scale expansion of NK, we demonstrate a greater than 30-fold increase (n = 7) in the number of activated natural killer cells (ANK) derived from CD5/CD8-depleted PBMNC when cultured for 35 days in supplemented DMEM/F12 versus RPMI 1640 basal medium (197.6 +/- 95.0-fold versus 6.3 +/- 2.1-fold, respectively). Serum-free media (AIM-V and X-VIVO 10) were unable to support NK proliferation. These data suggest that utilizing 2:1 DMEM/F12 + 2ME-containing supplements instead of standard RPMI 1640 as a basal medium can increase the proliferation of cytotoxic NK while reducing the culture interval and the amount of serum needed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551914     DOI: 10.1089/scd.1.1995.4.149

Source DB:  PubMed          Journal:  J Hematother        ISSN: 1061-6128


  8 in total

Review 1.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

2.  Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function--implications for the adoptive immunotherapy of leukaemia.

Authors:  J K Orleans-Lindsay; L D Barber; H G Prentice; M W Lowdell
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

3.  A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.

Authors:  Melissa A Geller; Sarah Cooley; Patricia L Judson; Rahel Ghebre; Linda F Carson; Peter A Argenta; Amy L Jonson; Angela Panoskaltsis-Mortari; Julie Curtsinger; David McKenna; Kathryn Dusenbery; Robin Bliss; Levi S Downs; Jeffrey S Miller
Journal:  Cytotherapy       Date:  2010-09-20       Impact factor: 5.414

4.  Study of Oligonucleotides Access and Distribution in Human Peripheral Blood Mononuclear Cells.

Authors:  Manuel Fernández-Delgado; Luis Sendra; María José Herrero; Gladys G Olivera-Pasquini; Alexander Batista-Duharte; Salvador F Aliño
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

5.  Isolation and characterization of canine natural killer cells.

Authors:  Helen T Michael; Daisuke Ito; Valarie McCullar; Bin Zhang; Jeffrey S Miller; Jaime F Modiano
Journal:  Vet Immunol Immunopathol       Date:  2013-06-28       Impact factor: 2.046

6.  A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.

Authors:  Emily J Pomeroy; John T Hunzeker; Mitchell G Kluesner; Walker S Lahr; Branden A Smeester; Margaret R Crosby; Cara-Lin Lonetree; Kenta Yamamoto; Laura Bendzick; Jeffrey S Miller; Melissa A Geller; Bruce Walcheck; Martin Felices; Beau R Webber; Timothy K Starr; Branden S Moriarity
Journal:  Mol Ther       Date:  2019-10-15       Impact factor: 11.454

7.  OP9 Feeder Cells Are Superior to M2-10B4 Cells for the Generation of Mature and Functional Natural Killer Cells from Umbilical Cord Hematopoietic Progenitors.

Authors:  Lara Herrera; Juan Manuel Salcedo; Silvia Santos; Miguel Ángel Vesga; Francisco Borrego; Cristina Eguizabal
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

8.  Feeder-Cell-Free and Serum-Free Expansion of Natural Killer Cells Using Cloudz Microspheres, G-Rex6M, and Human Platelet Lysate.

Authors:  Christopher D L Johnson; Nicole E Zale; Eric D Frary; Joseph A Lomakin
Journal:  Front Immunol       Date:  2022-03-07       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.